Rx (Prescription Medicine)
USD $ 120.00
Borviz 2.5mg Injection 是一种含有特定活性成分的药用产品，用于治疗各种医学病症，需遵医师处方使用。该注射剂通过靶向特定生物通路，缓解症状或治疗根本疾病。其作用机制取决于所含分子及适应症。
Borviz 2.5mg Injection 的适应症取决于其活性药物成分及获批的医学用途。务必遵循医生提供的剂量说明，用量和给药频次会根据您的具体需求和病史进行个体化调整。常见不良反应可能包括注射部位反应，如疼痛、红肿或肿胀。其他潜在不良反应将在患者信息叶底中详细列出，并需与您的医生讨论。Borviz 2.5mg Injection 应储存于室温，避光防潮，并置于儿童不易触及的地方。如对使用、潜在风险及收益有任何疑问，请务必咨询您的医疗提供者。
| Medicine Form | |
|---|---|
| Rx Status | |
| Medicine Type | |
| Molecule | |
| Brand Name | |
| Molecule | |
| Strength | 2.5 Mg |
| Medicine Form | Injection |
| Pack Quantity | 1 Vial |
| Packaging Type | Vial |
| Medicine Type | Generic |
| Country Of Origin | India |
| Rx Status | Rx (Prescription Medicine) |
未库存此 exact 强度的其他品牌，因此这些是其他强度的 Bortezomib. 未经开方医生建议，请勿更改剂量。
医学审核
Renu Meena, B.Pharm
Medical Content Writer
Renu Meena is an experienced Medical Content Writer with a strong foundation in pharmacy practice. She holds a Bachelor of Pharmacy (B.Pharm) degree from Rajasthan University of Health Sciences (RUHS), Jaipur, and is registered with the Rajasthan State Pharmacy Council (Reg. No. 55661). With 4+ years of experience across clinical pharmacy and medical content development, she creates evidence-based content for medicines, diseases, and patient education. Her work is shaped by a strong understanding of pharmacovigilance and regulatory standards, including ICH guidelines, GVP modules, ICD-10/11, and safety reporting requirements. Renu focuses on making complex medical information simple, accurate, and useful for readers while maintaining high quality and compliance.
